Skip to main content
PLOS One logoLink to PLOS One
. 2021 Jun 23;16(6):e0253588. doi: 10.1371/journal.pone.0253588

Pharmacist-led educational interventions provided to healthcare providers to reduce medication errors: A systematic review and meta-analysis

Myriam Jaam 1,‡,*, Lina Mohammad Naseralallah 1,#, Tarteel Ali Hussain 1,#, Shane Ashley Pawluk 2,3,
Editor: Mojtaba Vaismoradi4
PMCID: PMC8221459  PMID: 34161388

Abstract

Introduction

Medication errors are avoidable events that can occur at any stage of the medication use process. They are widespread in healthcare systems and are linked to an increased risk of morbidity and mortality. Several strategies have been studied to reduce their occurrence including different types of pharmacy-based interventions. One of the main pharmacist-led interventions is educational programs, which seem to have promising benefits.

Objective

To describe and compare various pharmacist-led educational interventions delivered to healthcare providers and to evaluate their impact qualitatively and quantitatively on medication error rates.

Methods

A systematic review and meta-analysis was conducted through searching Cochrane Library, EBSCO, EMBASE, Medline and Google Scholar from inception to June 2020. Only interventional studies that reported medication error rate change after the intervention were included. Two independent authors worked through the data extraction and quality assessment using Crowe Critical Appraisal Tool (CCAT). Summary odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using a random-effects model for rates of medication errors. Research protocol is available in The International Prospective Register of Systematic Reviews (PROSPERO) under the registration number CRD42019116465.

Results

Twelve studies involving 115058 participants were included. The two main recipients of the educational interventions were nurses and resident physicians. Educational programs involved lectures, posters, practical teaching sessions, audit and feedback method and flash cards of high-risk abbreviations. All studies included educational sessions as part of their program, either alone or in combination with other approaches, and most studies used errors encountered before implementing the intervention to inform the content of these sessions. Educational programs led by a pharmacist were associated with significant reductions in the overall rate of medication errors occurrence (OR, 0.38; 95% CI, 0.22 to 0.65).

Conclusion

Pharmacist-led educational interventions directed to healthcare providers are effective at reducing medication error rates. This review supports the implementation of pharmacist-led educational intervention aimed at reducing medication errors.

Introduction

Despite improvements in the medical field seen through advanced technology and computerized systems, we still witness medication errors taking place. Medication errors are defined by the National Coordinating Council for Medication Error Reporting and Prevention (NCCMERP) as “any preventable event that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of the health care professional, patient, or consumer” [1]. Numerous studies have reported that medication errors constitute a major reason for increased hospital stay, delayed medication administration, and an endless increase in medical costs [24]. In the United States 7,000 to 9,000 people die each year as a result of medication errors [5]. The global impact of medication errors as reported by the World Health Organization is estimated to be 42 billion USD each year [6]. The cost of a medication error can reach over $100 000 USD per patient [3].

The Majority of medication errors reported in the literature include prescribing errors requiring a pharmacist intervention [4, 79]. The reported prevalence of prescribing errors was reported to range from 2% to 94% [10]. These include among others, wrong drug, wrong dose, wrong route, wrong duration, and wrong formulation [711]. The results of a systematic review reporting error rates suggest that up to one prescribing error per patient takes place within a hospital setting [4]. Pharmacists are well-positioned to improve medication utilization and improve patient safety [12, 13].

Multiple interventions were tested for efficacy in reducing medication errors and studies have documented that pharmacists play a major role in reducing these medication errors [1417]. Ward-based clinical pharmacists reduce medication errors by providing real-time advice to physicians rather than recommending changes after prescribing has occurred [1820]. There is an important role of pharmacists in developing a medication safety strategy within their practice to reduce errors and improve the medication utilization process. One of the key elements of such a strategy is providing education to healthcare practitioners and prescribers since “too often, there is insufficient education of healthcare providers on medication safety topics” [13]. Educational interventions implemented by pharmacists within the pediatric ward have been reported to increase detection and reporting of medication errors while at the same time, reducing the severity of medication errors [21].

Pharmacist-led educational interventions seem to show benefit in reducing medication errors; however, it is not clear how often these educational sessions should run, nor what content should be included to provide optimal benefit in reducing medication errors [22]. To the best of our knowledge, this is the first systematic review and meta-analysis aimed to investigate the effectiveness of pharmacist-led educational interventions provided to healthcare providers to reduce medication errors both quantitatively and qualitatively.

Materials and methods

This systematic review and meta-analysis followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) reporting methodology [23]. The research protocol is available in The International Prospective Register of Systematic Reviews (PROSPERO) under the registration number CRD42019116465 [24].

Database and search strategy

Studies were captured from five databases: Cochrane Library, EBSCO, EMBASE, Medline, and Google Scholar, from inception until June 2020. In addition to databases, references of studies were also manually screened for relevant articles. To identify relevant studies, free text and MeSH terms were used and combined with Boolean operators ‘AND’ to combine terms of different categories and ‘OR’ to combine terms within one category. Table 1 summarizes the terms used for the search strategy. The limits applied include searching within title and abstract and using the English language in reporting the article. The search strategy was applied by two researchers, independently, to ensure consistency. Database hits and references identified from reference screening were then transferred to an excel sheet for removing duplicates. Screening of titles and abstracts was then completed by two independent authors. Any discrepancy was resolved through full-text screening of articles.

Table 1. Search terms.

Category Search terms
Category A Pharma*
Category B Medication errors OR Adverse effect OR mistake OR inappropriate prescribing OR safe prescribing OR medication discrepancy OR medication safety OR adverse drug event
Category C Prevent* OR Reduc* OR decrease OR augment OR effectiveness OR improvement
Category D Education OR training OR teach

Eligibility criteria

Articles were included if they (i) were published in English; (ii) investigated pharmacist-led educational interventions provided to healthcare providers, and (iii) reported medication error rate or number before and after the intervention.

Articles were excluded if they were (i) non-interventional descriptive studies, (ii) systematic reviews or meta-analyses, (iii) investigating pharmacy reconciliation and their effect on medication discrepancies, or (iv) were led by students or pharmacy technicians. Additionally, editorials, opinions, abstract-only studies were excluded.

Data extraction and quality assessment

A data extraction sheet was created and piloted on two randomly chosen included articles. The final data extraction form included: title, authors, year of publication, country, setting, objective, study type, medication error definition, outcome measure, the intervention provided, description of education provided, time frame, error rate -before and after-, conclusion, limitations and quality score. Whenever a study included multiple interventions, results of the pharmacist-led educational intervention alone were pooled out separately. The process was conducted by two independent researchers and consensus was sought through discussion.

The Crowe Critical Appraisal Tool (CCAT) was used for the quality assessment of included articles [25]. The CCAT covers eight domains: preliminary, introduction, design, sampling, data collection, ethical matters, results, and discussion. Each domain is scored out of five providing an overall score of 40 points which equates to a 100% score. The higher the score the better the quality of the article. Quality assessment was conducted by two independent researchers and the average overall quality score was used for reporting. The CCAT was previously used by the research team and high interrater reliability was demonstrated in previous research [26].

Data synthesis and analysis

Meta-analysis was performed using the Mantel-Haenszel odds ratio (OR) with a 95% confidence interval. A random-effect model was used due to differences in study locations, the population covered, and study interventions. P-value was also calculated to reflect the overall test effect and a value of less than 0.05 was considered to be significant. Cochrane Collaboration Review Manager (RevMan) version 5.3 was used for the analysis.

Results

Identification and selection of studies

A total of 9354 articles were identified from the different databases and reference screening. After duplicate studies were removed (n = 6857), the remaining articles were screened by title and abstract by two researchers. A total of 12 articles were included in the systematic review and meta-analysis Fig 1.

Fig 1. Prisma flow diagram.

Fig 1

Study characteristics

The characteristics of included studies are presented in Table 2. Studies captured were published from 2007 to 2019. The studies found were conducted in different countries including Egypt (n = 3) [2729], Australia (n = 2) [30, 31], USA (n = 2) [32, 33] and one each from Pakistan [34], Spain [35], Netherlands [36], Saudi Arabia [37] and Vietnam [38]. The majority of studies included looked at the pediatric population and covered different hospital units including neonatal/pediatric intensive care units (n = 3) [27, 35, 36], children ward [27], and one study was conducted in the pediatric surgery department [28]. Three studies covered multiple hospital departments [30, 32, 38] and three covered emergency/acute care hospital wards [29, 31, 37], while only one study was conducted in an outpatient clinic [33]. Medication error definition varied across the included studies; nonetheless, six studies covered prescribing errors which had a similar definition among the studies and included wrong drug, wrong dose, wrong frequency, wrong concentration, wrong or missed rate of administration, wrong or missed instructions for administration, unclear order or incomplete order [27, 28, 30, 32, 33, 35]. Additionally, medication errors included the use of error-prone abbreviations in prescribing in seven studies [27, 3033, 35, 37], Other medication errors captured by the studies were administration and preparation errors (n = 4) [29, 34, 36, 38] and medication error occurring at any stage [28].

Table 2. Study characteristics.

Author./year (Reference) Country/ Setting Targeted medication error Baseline measurement duration Baseline medication error rate Education provided Duration of intervention Education frequency Participants Medication error rate post-intervention (duration)
Ahmed et al. (2017) [27] Pakistan/ Children ward in a teaching hospital Administration errors 2 months 82.13% • Lectures (number, frequency and duration NR). 1 month NI Nurses 52.74%
(2 months)
• Preintervention errors informed content
• Covered: the types of medication administration errors made previously (based on patient charts) and reasons for these errors.
• A printed copy of the lecture was provided.
Alagha et al. (2011) [20] Egypt/ PICU Prescribing errors 5 months 78.10% • Lectures (number and duration NR) NI Once New resident physicians 35.20%
• Preintervention errors informed content (5 months)
• Covered: Good prescribing and prescription writing, introducing new order chart, medication errors and their consequences, and orientation to the drug use assists and their use.
• A printed copy of the lectures was provided.
• A dosing sheet for the commonly used drugs (IV, oral, inhalation) was provided to residents and a copy was made available in all patient files.
• All residents received individualized written reports about their errors throughout the post-intervention phase.
Campino et al. (2009) [28] Spain/ NICU Prescribing errors 5 months 20.70% • 15 informative sessions (duration NR) 4 months Fifteen All health professionals 3.00%
• Covered: medication errors, a non-punitive culture on patient safety, and study aim. (2 months)
Chedoe et al. (2012) [29] Netherlands/ NICU Preparation and administration errors 1 month 49.00% • Theoretical teaching session (five, 1 hour each) 26 months Six (5 lectures, 1 practical session) Nurses 31.00%
(1 month)
• Covered: calculation, reconstitution, compatibilities, administration rate, and aseptic technique of drug preparation and administration
• Individual practical teaching session (once for around 30 minutes)
• Covered: preparation and administration of all common ward medication and a short guided tour around the pharmacy department.
• Teaching aids: a PowerPoint presentation, a video presentation, made available on the hospital’s intranet.
• A poster with recommendations for safe preparation and administration was placed in the preparation area. All guidelines outlining drug preparation and administration were updated and available on the ward.
Fawaz et al. (2017) [21] Egypt/ Pediatric surgery department in a teaching hospital Medication errors including all stages (Prescribing, transcribing, Administration) categorized according to the NCCMERP NI 33.33% • One educational session (duration NR) NI Once Physicians (pediatric surgery and anesthesia residents) 32.32%
• Covered: definition of medication errors, medication use process, the difference between medication errors and adverse drug events, barriers to reporting medication errors, categories of medication errors according to the NCCMERP, types of medication errors, USP medication errors reporting program, prevention strategies, and the role of clinical pharmacist in the operating room. (NI)
Gursanscky et al. (2018) [23] Australia/ Four general medical units in a tertiary hospital Prescribing errors 3 weeks 58.00% • Three 10-min educational sessions per week 4 weeks 3 sessions / week Junior doctors 37.00%
• Covered: frequency, type, and severity of prescribing errors. The pharmacist discussed why the errors were considered incorrect or unsafe, the potential consequences of such errors, and the correct way to prescribe. Any questions or ambiguities were addressed. Subsequent sessions addressed the next most common and serious errors, usually covering two to three error types per session. (1 month)
• Preintervention errors informed content using data from the 1–2 days immediately preceding each session.
• A printed copy of the lecture was provided.
Haseeb et al. (2016) [30] Saudi Arabia/ Acute care hospital Use HRA 1 month 53.60% • A series of interactive lectures (number, frequency, and duration NR) 1 month NI All health professionals (i.e. doctors, nurses, pharmacists, and relevant assistants) 25.50%
(1 month)
• Covered: basic concepts of prescribing and dispensing errors, negative consequences of using HRAs in an emergency setting, and error prevention based on the Institute for Safe Medical Practices and the US Food and Drug Administration
• A printed list of abbreviations was inserted into medical records/patient charts, placed next to all hospital computers, and posted in the patient care area
• Pocket-sized flashcards with the HRA list provided for all staff
• Patient safety posters given to the hospital wards explaining HRA
Mostafa et al. (2019) [22] Egypt/ Emergency hospital Administration and preparation error categorized according to the NCCMERP NI 34.20% • Lectures (number, frequency, and duration NR) NI NI Nurses 15.30%
(NI)
• Covered: medication safety, general advice about administering medications, as was a list of all the medications available in the emergency hospital, with a brief explanation of the proper administration techniques and storage precautions.
• Posters of medications and their proper administration were hung in all emergency departments and the emergency pharmacy. of
• Lectures and posters were in the Arabic language to make it easier for nurses to understand.
Nguyen et al. (2013) [31] Vietnam/ ICU and PSU IV medications preparation and administration errors 1 week 64.00% • Training program including classroom lectures: two 30-min teaching sessions with PowerPoint presentation 2 weeks Three (2 lectures, 1 practical session) Nurses 48.90%
(1 week)
• covered: reconstitution, compatibility, administration rate, and drug preparation and administration techniques
• Practice-based education: one 45-min practical session covering the preparation and administration of commonly used medications and including discussion of patient cases
• Two posters on recommended practice for safe preparation and administration and emphasizing the adverse consequences of inappropriate procedures were attached to the wall of the preparation area.
• Written guidelines on the preparation and administration of commonly used IV drugs were made available on the ward.
Peeters et al. (2009) [25] USA/ 13 hospital units Prescribing errors 1 month 2.25% • Divided into two phases: Phase 1—an hour-long lecture 6 months Phase 1: once Internal medicine residents After phase 1 and early into phase 2: 1.51%
• covered: definitions and categories of medical errors and medication errors, Institute of Medicine reports, Joint Commission medication management requirements, and institutional medication order policies • Phase 2: biweekly for 2 months then monthly for 4 months
Post-intervention: 2.33%
• Phase 2: a series of short (15 minutes), follow-up discussion sessions (1 month)
• covered: prescribing errors identified
• Preintervention errors informed content
Taylor et al.(2007) [24] Australia/ ED Error-prone prescribing abbreviations 1 week 31.80% • Educational sessions (duration NR) in the form of small-group or one-on-one tutorials 5 months NI Prescribing physicians and nurses 18.70%
(1 week)
• Distribution of name badge sized cards summarizing the information
• Placement of posters in the ED
Winder et al. (2015) [26] USA/ Outpatient academic family medicine clinic Prescribing error 1 month 18.60% • The first intervention (optional) was one educational outreach visit delivered over 1 hour First intervention: once. First intervention: once. Resident physicians 14.50%
(1 week)
• Covered: prescribing errors, applicable use of tools available in the EMR, drug information resources available within the EMR, and necessary elements for writing a prescription, unavailable medications, unapproved abbreviations, new medication labeling, the prescription review process, and questions using an audience response system as well as practice calculations for pediatric prescriptions. Second intervention: 3 months Second intervention: weekly
• Preintervention errors informed content
• The second intervention involved the implementation of an audit and feedback method and a weekly newsletter.
• All residents received individualized written reports about their errors via EMR alerts. Errors found were reported to the institution’s risk management department.
• Verbal feedback was provided as needed to prescribers based upon the level of severity of the error.
• Additionally, over 3 months following the educational outreach, all residents were sent a weekly newsletter of common errors via the family medicine email list. Weekly newsletters included contact information for clinical pharmacists, common errors identified during the previous week, error type, examples of the error, recommendations for correction, and highlights from the educational outreach.

PICU: Pediatric Intensive Care Unit. NICU: Neonatal Intensive Care Unit. PSU: Post-Surgical Unit. ED: Emergency Department. IV: Intravenous. NI: Not indicated. NR: Not reported. NCCMERP: The National Coordinating Council for Medication Error Reporting and Prevention. HRA: High-Risk Abbreviation. EMR: Electronic Medical Record

Quality of included studies

Two raters with previous experience with using the CCAT [26] appraised each of the 12 studies, which resulted in 24 independent CCAT evaluations. The average score was reported (Table 3). The total score ranged from 56.25% to 92.5% and the overall assessment mean for all studies was 74.68%. Within the CCAT sections, the highest scores were for preliminary and introduction (4.42/5), while the lowest were for sampling (3.17/5) and ethics (2.67/5) (Table 3).

Table 3. Cumulative quality assessment results.

Study Preliminary Introduction Design Sampling Data analysis Ethics Results Discussion Overall Out of 40 (%)
Ahmed et al [27] 3.00 3.00 3.00 1.50 3.50 3.00 3.00 2.50 22.50
(56.25%)
Alagha et al [20] 5.00 5.00 3.00 0.00 2.00 0.00 5.00 5.00 25.00
(62.50%)
Campino et al [28] 5.00 4.00 5.00 3.00 4.00 1.00 3.00 3.00 28.00
(70.00%)
Chedoe et al [29] 5.00 5.00 4.00 4.00 5.00 4.00 5.00 5.00 37.00
(92.50%)
Fawaz et al [21] 4.00 2.00 3.50 2.50 3.50 1.50 3.50 3.00 23.50
(58.75%)
Gursanscky et al [23] 5.00 5.00 5.00 5.00 4.00 1.00 4.00 5.00 34.00
(85.00%)
Haseeb et al [30] 5.00 5.00 5.00 5.00 4.00 2.00 4.00 5.00 35.00
(87.50%)
Mostafa et al [22] 4.00 4.50 3.00 1.00 3.50 4.50 3.50 3.50 27.50
(68.75%)
Nguyen et al [31] 5.00 5.00 5.00 3.00 4.00 4.00 4.00 5.00 35.00
(87.50%)
Peeters et al [25] 4.00 5.00 4.00 5.00 4.00 2.00 2.00 4.00 30.00
(75.00%)
Taylor et al [24] 3.00 5.00 2.00 4.00 3.00 4.00 3.00 2.00 26.00
(65.00%)
Winder et al [26] 5.00 4.50 4.00 4.00 4.00 5.00 4.50 4.00 35.00
(87.50%)
Overall 4.42 4.42 3.88 3.17 3.71 2.67 3.71 3.92 29.88
(74.68%)

Description of educational interventions

The 12 studies included in this review involved pharmacist-led educational interventions that varied in content, recipient group, duration, and frequency of delivery. The educational interventions targeted nurses (n = 4) with a focus on medication preparation and administration errors [29, 34, 36, 38] and resident physicians (n = 4) which focused on prescribing errors [27, 28, 32, 33]. The period of the interventions covered a wide range of duration with the longest being 26 months [36] and the shortest was conducted over two weeks [38], however, the investigators within three studies did not report intervention duration [2729].

All included studies delivered informative didactic lectures as part of their intervention. This was a sole intervention in six studies [27, 28, 30, 32, 34, 35] or was combined with other forms of educational interventions, including posters (n = 5) [29, 31, 3638]; practical teaching sessions [36, 38]; audit and feedback method along with a weekly newsletter [33]; and pocket-sized flashcards of high-risk abbreviations [37]. Studies that included posters in addition to lectures indicated that the posters were placed in the ward and included important recommendations and guidance for healthcare providers. On the other hand, studies that included practical teaching sessions covered preparation and administration of commonly used medications in addition to individualized 30-minute sessions delivered to new residents or 45-minutes group discussions of patient cases [36, 38].

The frequency of the educational sessions varied from once only in two studies [27, 28] to a total of 21 sessions over a period of six months [32] while it was not reported in four studies [29, 31, 34, 37]. All studies did not report the number and duration of lectures, except for Chedoe et al (five 1-hour sessions) [36]; Gursanscky et al (twelve 10-minutes sessions) [30]; Nguyen et al (two 30-minutes sessions) [38]; Peeters et al (phase 1: one 1-hour session, phase 2: eight 15-minutes sessions) [32]; and Winder et al (one 1-hour session) [33]. Five out of the twelve studies distributed printed handouts that summarized the lecture content [27, 30, 31, 34, 37].

Different teaching aids were used during the lectures, such as PowerPoint presentation slides [36, 38], video presentation [36], or audience response system [33]. Seven studies used errors encountered before the sessions or error rates captured at the pre-intervention phase to inform the content of these sessions [27, 2931, 33, 34, 38]. The educational sessions mostly covered aspects such as definition, type, causes, consequences, and prevention methods. Studies that focused on prescribing errors covered good prescription writing including the use of appropriate abbreviations within their educational sessions, while studies that focused on administration and preparation errors covered more technical teaching such as calculations, reconstitution, compatibilities, and drug administration rate. The number of attendees at educational sessions was not clear in all studies, and no description was provided on how attendees were informed about the educational sessions (Table 2).

Effect of educational interventions

All studies included in the systematic review were eligible for meta-analysis (Fig 2). Ten of twelve studies indicated a clear and significant decrease in the incidence of medication errors after implementing a pharmacist-led educational intervention [27, 2931, 3338]. The pooled OR (n = 115 058 participants) across all studies was 0.38 (95% CI 0.22 to 0.65) (P = 0.0004). However, the results of these studies were substantially heterogeneous (Fig 2). Only two studies [28, 32] conducted in the USA and Egypt showed no significant difference in the occurrence of medication errors after applying the intervention. The study conducted in the USA had a very low rate of medication errors relative to other included studies and was divided into two phases, in which a significant reduction was observed during the intervention, but was not maintained one month post-intervention [32]. The educational intervention for the study conducted in Egypt consisted of one educational session, without follow-up sessions or distributing a printed copy of the lecture, and it showed a nonsignificant reduction of medication errors after the study intervention [28].

Fig 2. Random effect model of pharmacist-led education and its association with medication errors.

Fig 2

Discussion

Majority of pharmacist-led interventions—targeting medication errors—reported in the literature focus on medication reconciliation or education provided to patients rather than healthcare providers [3941]. This paper has shown an overall better outcome in favor of pharmacist-led educational interventions provided to healthcare providers on the rate of medication error occurrence.

Although most included studies showed improvement, two papers did not show a significant difference after implementing the intervention. The educational intervention in the first study conducted by Fawaz et al consisted of one lecture delivered to physicians without providing any printout or posters to summarize the content of the lecture which can serve as a constant reminder to recipients [28]. In the second study which was conducted by Peeters et al., pharmacists delivered frequent lectures to residents throughout six months, yet the benefit was only noted during the intervention period but was not maintained one month post-intervention [32]. This could be due to the initial very low rate of medication errors relative to other included studies in this review. Additionally, similar to Fawaz et al. study, the study by Peeters et al. did not provide any form of constant reminder (e.g. printouts or posters) as part of the educational intervention. Multiple studies showed that various educational strategies, such as brochures or training activities, have beneficial outcomes including improving different aspects of knowledge and skills of healthcare workers [4244]. This benefit is also highlighted within the four studies that used printed handouts which resulted in significant reduction in medication error rates, including the trial conducted by Alagha et al., which used only one educational session [27, 30, 31, 34, 37]. In addition to the printed materials, Alagha et al. and Winder et al. provided individualized reports (written and through Electronic Medical Record (EMR) respectively) to the resident physicians about their own errors. This approach might have contributed to the significant reduction in medication errors in these studies because each resident would avoid the factors that lead to their prescribing errors; hence minimize them [27, 33].

The most intensive intervention was the one conducted by Winder et al. [33]. Within this study, researchers implemented multi-faceted interventions to reduce prescribing errors. This included four phases: a pre-intervention error assessment; followed by an optional educational intervention delivered to resident physicians; and error notification intervention through an audit and direct feedback to residents electronically and verbally depending on the error severity. This phase also included sending weekly newsletters of common errors over a period of three months and post-intervention error assessment conducted after one year. Within this study, the pediatric dosing errors were 36% lower among residents who attended the educational sessions compared to those who did not. This approach highlights the importance of continued audit and direct feedback to improve patient safety to be conducted along with healthcare practitioners’ education. The importance of continuous electronic audit and feedback was, similarly, emphasized upon by a study conducted in the UK which covered over 40 general practices [45].

Additionally, the frequency and duration of educational intervention can play a role in maintaining good outcomes. It was noted that studies that used more frequent educational sessions such as the one reported by Campino and Gursanscky providing 15 and 12 sessions within four months and one month respectively, had better outcomes compared to other studies [30, 35]. Repeated encounters–as reported by Bruner–improves information retention [46]. It must be highlighted though that the mere repetition of the sessions might not be sufficient in improving practice. Brabeck et al. highlighted that deliberate practice significantly improves cognitive gain and brings about the motivation for more learning, hence, better performance [47]. Therefore, the frequent educational sessions should always have a component of the application to have a better outcome.

The results of this meta-analysis highlight that many factors can lead to a significant reduction in medication errors post educational sessions. Medication errors can significantly reduce if pharmacists invest in providing education to healthcare providers that are supplemented with printed handouts summarizing the lecture content. Additionally, the provision of individualized medication error reports and the use of ward-based posters addressing preparation and administration errors can also help reduce prescribing and medication administration errors. For ease of access, pharmacists can also work on providing flashcards with instructions for good prescribing including high-risk abbreviations when addressing prescribing errors. Finally, having frequent application-based educational sessions can be of great benefit to healthcare providers.

Additionally, majority of the included studies used errors reported before the educational sessions to inform the content. Such an approach can contribute to the benefit observed in reduced medication errors. Based on the results of this systematic review, the authors recommend using frequent educational sessions supplemented with individualized prescriber reports to significantly minimize medication errors. The session content should be site-specific based on the types of medication errors encountered and summary material should be provided to attendees. Many articles emphasized the importance of continuous monitoring and reporting of errors to maintain a safe practice and reduce patient harm [4850]. As such, these continuous reports should inform the content of the educational sessions.

The quality of reporting of the included studies was of an acceptable level. Nonetheless, the authors believe it can always be improved through the utilization of reporting tools. Within the CCAT, the item which scored the least was ethics which focuses on reporting of consent, ethics approval, and anonymity of data. This was followed by “sampling”, which includes three components: sampling method, sample size, and sampling protocol. Sampling is a very important component that can affect the study power to detect a difference and can also affect the generalizability of the results [51]. Research on medication errors should maximize its quality through the use of reporting tools and checklists available in the literature and the Enhancing the QUAlity and Transparency of health Research (EQUATOR) Network [52].

Our results are consistent with previous systematic reviews and meta-analyses that studied the effectiveness of different clinical pharmacist interventions on medication error rates in adults and pediatric patients at diverse hospital departments [26, 41, 5357]. The studies included multiple interventions such as reviewing orders, implementing a ward-based pharmacist, or designing educational programs. However, none of these papers focused on educational interventions or had a subgroup analysis to investigate their effectiveness in decreasing medication errors. Nonetheless, Manias et al. published a recent systematic review of all interventions to reduce medication errors in adult medical and surgical units which described similar outcomes to this systematic review. Pharmacist-led interventions were of great benefit and educational interventions to healthcare providers proved to be effective in reducing medication errors [58]. This emphasizes the importance of having drug experts take lead in delivering education to their colleagues.

Limitations within this study need to be acknowledged. Significant heterogeneity in the studies included in the meta-analysis was reported. This is due to major differences in the delivery of the educational sessions, variation in the settings, and differences in the type and definition of the targeted medication error. Additionally, almost all studies reported positive results with the pharmacist-led educational intervention and we cannot exclude the risk of publication biases. Moreover, the researchers within the included studies might have chosen the areas that are likely to show positive results since they included acute care, pediatric, and emergency settings. The off-label, unlicensed use of medicines, weight-related dose adjustment, and other dosing calculations are widespread in these settings particularly in pediatrics, which may increase the risk of avoidable medication-associated harm. Therefore, they are more likely to report positive results. In addition, the setting for this review was mainly inpatient with only one study reporting findings in the outpatient setting. As a result, our findings are unlikely to be generalizable to all healthcare systems. Finally, the authors acknowledge that excluding non-interventional studies might have precluded many potentially good and relevant articles. However, the authors focused on interventional studies which are generally recognized as stronger evidence generating studies with less confounding [59].

Future investigations and randomized controlled studies are required to evaluate the impact of pharmacist-led educational intervention on other types of medication errors not covered in the studies included in this review, such as transcribing, dispensing, and monitoring errors. This will provide a broader picture of the capability of the pharmacists in providing effective education to healthcare providers that minimize all types of medication errors. The effect of pharmacist-led education to healthcare providers on medication errors in outpatient settings should gain more attention in further studies. This might include outpatient clinics, home care, and community pharmacies. The elderly population may also encounter special issues related to medication errors. For example, people living in care homes are often frail with multiple health conditions and take multiple medications. The administration of medication in this environment often differs to patients’ own homes as it is provided by nursing staff or other personnel, thus raising particular issues around dispensing, administration, and monitoring problems, as well as staff training. Additionally, many pharmacist-led interventions target medication errors apart from providing education to healthcare providers, including providing medication reconciliation; including pharmacists inwards; and involving them in team discussions [3941]. A study that compares the benefit of these interventions and determining priority intervention will be of significant benefit especially in areas where resources are limited. Medication errors are known to be linked to morbidity and mortality as highlighted by the well-cited report “To Err is human” [60], therefore, future studies should consider the outcome of morbidity and mortality as an extended outcome to medication error rates. This will provide a better understanding of the consequences of interventions done to tackle medication errors. Finally, the economic impact of this intervention and associated cost saving studies related to education can support resource allocation and improve patient safety.

Conclusion

This systematic review and meta-analysis demonstrated that pharmacist-led educational interventions to healthcare providers are effective in reducing medication errors. The educational intervention was observed to be most effective when supplemented with printed handouts that summarize the session content, providing posters or pocket-sized flashcards to prescribers, and when healthcare providers receive an individualized written or electronic report about their medication errors. Additionally, frequent educational sessions were observed to be more effective than one-time sessions. These combined approaches serve as constant reminders to the healthcare practitioners to minimize medication errors at different stages of the medication-use process. Further research should consider the effect on morbidity, mortality related to medication errors and the economic impact of pharmacist-led education provided to healthcare providers.

Supporting information

S1 Checklist. PRISMA checklist.

(DOC)

S1 File. Search strategy.

(DOCX)

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.National Coordinating Council for Medication Error Reporting and Prevention. About medication errors [cited 2018 Nov 11]. Available from: http://www.nccmerp.org/aboutMedErrors.html.
  • 2.Wittich CM, Burkle CM, Lanier WL. Medication errors: an overview for clinicians. Mayo Clin Proc. 2014;89(8):1116–25. doi: 10.1016/j.mayocp.2014.05.007 [DOI] [PubMed] [Google Scholar]
  • 3.Walsh EK, Hansen CR, Sahm LJ, Kearney PM, Doherty E, Bradley CP. Economic impact of medication error: a systematic review. Pharmacoepidemiol Drug Saf. 2017;26(5):481–97. doi: 10.1002/pds.4188 [DOI] [PubMed] [Google Scholar]
  • 4.Roughead EE, Semple SJ, Rosenfeld E. The extent of medication errors and adverse drug reactions throughout the patient journey in acute care in Australia. Int J Evid Based Healthc. 2016;14(3):113–22. doi: 10.1097/XEB.0000000000000075 [DOI] [PubMed] [Google Scholar]
  • 5.Tariq RA, Vashisht R, Sinha A, Scherbak Y. Medication Dispensing Errors And Prevention [Updated 2021 May 12]. In: StatPearls [Internet]. [Cited 2021 May 28];Treasure Island (FL): StatPearls Publishing; 2021. Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK519065/ . [PubMed] [Google Scholar]
  • 6.World Health Organization. Medication Without Harm—Global Patient Safety Challenge on Medication Safety, 2017. Geneva: World Health Organization, 2017. Licence: CC BY-NC-SA 30 IGO. [cited 2021 May 28];Available from: http://www.gims-foundation.org/wp-content/uploads/2017/05/WHO-Brochure-GPSC_Medication-Without-Harm-2017.pdf. [Google Scholar]
  • 7.Keers RN, Williams SD, Cooke J, Ashcroft DM. Causes of medication administration errors in hospitals: a systematic review of quantitative and qualitative evidence. Drug Saf. 2013;36(11):1045–67. doi: 10.1007/s40264-013-0090-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Bjorksten KS, Bergqvist M, Andersen-Karlsson E, Benson L, Ulfvarson J. Medication errors as malpractice-a qualitative content analysis of 585 medication errors by nurses in Sweden. BMC Health Serv Res. 2016;16(1):431. doi: 10.1186/s12913-016-1695-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Sabzi Z, Mohammadi R, Talebi R, Roshandel GR. Medication Errors and Their Relationship with Care Complexity and Work Dynamics. Open Access Maced J Med Sci. 2019;7(21):3579–83. doi: 10.3889/oamjms.2019.722 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Assiri GA, Shebl NA, Mahmoud MA, Aloudah N, Grant E, Aljadhey H, et al. What is the epidemiology of medication errors, error-related adverse events and risk factors for errors in adults managed in community care contexts? A systematic review of the international literature. BMJ Open. 2018;8(5):e019101. doi: 10.1136/bmjopen-2017-019101 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Pawluk S, Jaam M, Hazi F, Al Hail MS, El Kassem W, Khalifa H, et al. A description of medication errors reported by pharmacists in a neonatal intensive care unit. Int J Clin Pharm. 2017;39(1):88–94. doi: 10.1007/s11096-016-0399-x [DOI] [PubMed] [Google Scholar]
  • 12.De Oliveira GS Jr., Castro-Alves LJ, Kendall MC, McCarthy R. Effectiveness of Pharmacist Intervention to Reduce Medication Errors and Health-Care Resources Utilization After Transitions of Care: A Meta-analysis of Randomized Controlled Trials. J Patient Saf. 2017. doi: 10.1097/PTS.0000000000000283 [DOI] [PubMed] [Google Scholar]
  • 13.Mansur JM. Medication Safety Systems and the Important Role of Pharmacists. Drugs Aging. 2016;33(3):213–21. doi: 10.1007/s40266-016-0358-1 [DOI] [PubMed] [Google Scholar]
  • 14.George D, Supramaniam ND, Hamid SQA, Hassali MA, Lim W-Y, Hss A-S. Effectiveness of a pharmacist-led quality improvement program to reduce medication errors during hospital discharge. Pharm Pract. 2019;17(3):1501. doi: 10.18549/PharmPract.2019.3.1501 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Riordan DO, Walsh KA, Galvin R, Sinnott C, Kearney PM, Byrne S. The effect of pharmacist-led interventions in optimising prescribing in older adults in primary care: A systematic review. SAGE Open Med. 2016;4. doi: 10.1177/2050312116652568 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.de Araújo BC, de Melo RC, de Bortoli MC, Bonfim JRdA, Toma TS. How to Prevent or Reduce Prescribing Errors: An Evidence Brief for Policy. Front Pharmacol. 2019;10:439. 10.3389/fphar.2019.00439 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Pharmacists’ impact on patient safety: A joint project of the american pharmacists association academy of pharmacy practice and management and academy of pharmaceutical research and science. Washington, DC: 2016. [cited 2021 Jan 2]. Available from: https://pharmacist.com/Portals/0/PDFS/Practice/PharmacistsImpactonPatientSafety_Web.pdf?ver=dYeAzwlN3-PG9eSkMMsV-A%3D%3D
  • 18.Pfister B, Jonsson J, Gustafsson M. Drug-related problems and medication reviews among old people with dementia. BMC Pharmacol Toxicol. 2017;18(1):52. doi: 10.1186/s40360-017-0157-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Sjölander M, Lindholm L, Pfister B, Jonsson J, Schneede J, Lövheim H, et al. Impact of clinical pharmacist engagement in ward teams on the number of drug-related readmissions among older patients with dementia or cognitive impairment: An economic evaluation. Res Social Adm Pharm. 2019;15(3):287–91. doi: 10.1016/j.sapharm.2018.05.006 [DOI] [PubMed] [Google Scholar]
  • 20.Alex S, Adenew AB, Arundel C, Maron DD, Kerns JC. Medication Errors Despite Using Electronic Health Records: The Value of a Clinical Pharmacist Service in Reducing Discharge-Related Medication Errors. Qual Manag Health Care. 2016;25(1):32–7. doi: 10.1097/QMH.0000000000000080 [DOI] [PubMed] [Google Scholar]
  • 21.Costello JL, Torowicz DL, Yeh TS. Effects of a pharmacist-led pediatrics medication safety team on medication-error reporting. Am J Health Syst Pharm. 2007;64(13):1422–6. doi: 10.2146/ajhp060296 [DOI] [PubMed] [Google Scholar]
  • 22.Likic R, Maxwell SRJ. Prevention of medication errors: teaching and training. Br J Clin Pharmacol. 2009;67(6):656–61. doi: 10.1111/j.1365-2125.2009.03423.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Jaam M. Pawluk S. Pharmacist-led educational interventions provided to healthcare providers to reduce medication errors. PROSPERO 2019 CRD42019116465 Available from: https://wwwcrdyorkacuk/prospero/display_recordphp?ID=CRD42019116465. 2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Crowe M, Sheppard L., & Campbell A.,. Crowe Critical Appraisal Tool (v1.4). 2013. [cited 2021 Jan 1] Available from: https://conchracomau/2015/12/08/crowe-critical-appraisal-tool-v1-4/. [Google Scholar]
  • 26.Naseralallah LM, Hussain TA, Jaam M, Pawluk SA. Impact of pharmacist interventions on medication errors in hospitalized pediatric patients: a systematic review and meta-analysis. Int J Clin Pharm. 2020;42(4):979–94. doi: 10.1007/s11096-020-01034-z [DOI] [PubMed] [Google Scholar]
  • 27.Alagha HZ, Badary OA, Ibrahim HM, Sabri NA. Reducing prescribing errors in the paediatric intensive care unit: an experience from Egypt. Acta Paediatr. 2011;100(10):e169–74. doi: 10.1111/j.1651-2227.2011.02270.x [DOI] [PubMed] [Google Scholar]
  • 28.Fawaz MG SN, Albaghdady AA, Malek FAA.,. Detection and prevention of medication errors in the operating rooms of a pediatric surgery department in Egypt. Int J Pharm Sci Rev Res. 2017;42:100–6. [Google Scholar]
  • 29.Mostafa LS, Sabri NA, El-Anwar AM, Shaheen SM. Evaluation of pharmacist-led educational interventions to reduce medication errors in emergency hospitals: a new insight into patient care. J Public Health (Oxf). 2020;42(1):169–74. doi: 10.1093/pubmed/fdy216 [DOI] [PubMed] [Google Scholar]
  • 30.Gursanscky J, Young J, Griffett K, Liew D, Smallwood D. Benefit of targeted, pharmacist-led education for junior doctors in reducing prescription writing errors–a controlled trial. J Pharm Pract Res. 2018;48(1):26–35. 10.1002/jppr.1330 [DOI] [Google Scholar]
  • 31.Taylor SE, Chu MT-Y, Haack LA, McGrath A, To T-P. An Intervention to Reduce the Use of Error-Prone Prescribing Abbreviations in the Emergency Department. J Pharm Pract Res. 2007;37(3):214–6. 10.1002/j.2055-2335.2007.tb00747.x [DOI] [Google Scholar]
  • 32.Peeters MJ, Pinto SL. Assessing the impact of an educational program on decreasing prescribing errors at a university hospital. J Hosp Med. 2009;4(2):97–101. doi: 10.1002/jhm.387 [DOI] [PubMed] [Google Scholar]
  • 33.Winder M JJ, Planas L, Crosby K, Gildon B, Oberst-Walsh L. Impact of pharmacist-led educational and error notification interventions on prescribing errors in a family medicine clinic. J Am Pharm Assoc. 2015;55:238–45. doi: 10.1331/JAPhA.2015.14130 [DOI] [PubMed] [Google Scholar]
  • 34.Ahmed T HN, Rehman M, Nasim A. The impact of pharmacist intervention on medication errors in a teaching hospital Quetta, Pakistan. Value Health. 2016;19(A630). doi: 10.1016/j.jval.2016.09.1632 [DOI] [Google Scholar]
  • 35.Campino A, Lopez-Herrera MC, Lopez-de-Heredia I, Valls-i-Soler A. Educational strategy to reduce medication errors in a neonatal intensive care unit. Acta Paediatr. 2009;98(5):782–5. doi: 10.1111/j.1651-2227.2009.01234.x [DOI] [PubMed] [Google Scholar]
  • 36.Chedoe I, Molendijk H, Hospes W, Van den Heuvel ER, Taxis K. The effect of a multifaceted educational intervention on medication preparation and administration errors in neonatal intensive care. Arch Dis Child Fetal Neonatal Ed. 2012;97(6):F449–55. doi: 10.1136/fetalneonatal-2011-300989 [DOI] [PubMed] [Google Scholar]
  • 37.Haseeb A, Winit-Watjana W, Bakhsh A-RR, Elrggal ME, Hadi MA, Mously AA, et al. Effectiveness of a pharmacist-led educational intervention to reduce the use of high-risk abbreviations in an acute care setting in Saudi Arabia: a quasi-experimental study. BMJ Open. 2016;6(6):e011401. doi: 10.1136/bmjopen-2016-011401 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Nguyen HT, Pham HT, Vo DK, Nguyen TD, van den Heuvel ER, Haaijer-Ruskamp FM, et al. The effect of a clinical pharmacist-led training programme on intravenous medication errors: a controlled before and after study. BMJ Qual Saf. 2014;23(4):319–24. doi: 10.1136/bmjqs-2013-002357 [DOI] [PubMed] [Google Scholar]
  • 39.Mekonnen AB, McLachlan AJ, Brien JA. Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis. BMJ Open. 2016;6(2):e010003. doi: 10.1136/bmjopen-2015-010003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Khalil H, Bell B, Chambers H, Sheikh A, Avery AJ. Professional, structural and organisational interventions in primary care for reducing medication errors. Cochrane Database Syst Rev. 2017;10(10) doi: 10.1002/14651858.CD003942.pub3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Manias E, Williams A, Liew D. Interventions to reduce medication errors in adult intensive care: a systematic review. Br J Clin Pharmacol. 2012;74(3):411–23. doi: 10.1111/j.1365-2125.2012.04220.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Bester N, Di Vito-Smith M, McGarry T, Riffkin M, Kaehler S, Pilot R, et al. The Effectiveness of an Educational Brochure as a Risk Minimization Activity to Communicate Important Rare Adverse Events to Health-Care Professionals. Adv Ther. 2016;33(2):167–77. doi: 10.1007/s12325-016-0284-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Chung H-O, Oczkowski SJW, Hanvey L, Mbuagbaw L, You JJ. Educational interventions to train healthcare professionals in end-of-life communication: a systematic review and meta-analysis. BMC Med Educ. 2016;16(1):131. doi: 10.1186/s12909-016-0653-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Abu Farha R, Abu Hammour K, Rizik M, Aljanabi R, Alsakran L. Effect of educational intervention on healthcare providers knowledge and perception towards pharmacovigilance: A tertiary teaching hospital experience. Saudi Pharm J. 2018;26(5):611–6. doi: 10.1016/j.jsps.2018.03.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Peek N, Gude WT, Keers RN, Williams R, Kontopantelis E, Jeffries M, et al. Evaluation of a pharmacist-led actionable audit and feedback intervention for improving medication safety in UK primary care: An interrupted time series analysis. PLOS Med. 2020; 17(10). doi: 10.1371/journal.pmed.1003286 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Bruner RF. Repetition is the first principle of all learning. 2001. [cited 2021 Jan 1]. Available at SSRN: https://ssrncom/abstract=224340. [Google Scholar]
  • 47.Brabeck M, & Jeffrey J.,. Practice for knowledge acquisition (not drill and kill): American Psychological Association; 2010. [cited 2020 Jan 1]. Available from: doi: 10.1016/j.bbrc.2010.02.015 [DOI] [Google Scholar]
  • 48.Elden NMK, Ismail A. The Importance of Medication Errors Reporting in Improving the Quality of Clinical Care Services. Glob J Health Sci. 2016;8(8):243–251. doi: 10.5539/gjhs.v8n8p243 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Tran T, Taylor SE, Hardidge A, Mitri E, Aminian P, George J, et al. The Prevalence and Nature of Medication Errors and Adverse Events Related to Preadmission Medications When Patients Are Admitted to an Orthopedic Inpatient Unit: An Observational Study. Ann Pharmacother. 2019;53(3):252–60. doi: 10.1177/1060028018802472 [DOI] [PubMed] [Google Scholar]
  • 50.Lewis PJ, Dornan T, Taylor D, Tully MP, Wass V, Ashcroft DM. Prevalence, incidence and nature of prescribing errors in hospital inpatients: a systematic review. Drug Saf. 2009;32(5):379–89. doi: 10.2165/00002018-200932050-00002 [DOI] [PubMed] [Google Scholar]
  • 51.Elfil M, Negida A. Sampling methods in Clinical Research; an Educational Review. Emerg. 2017;5(1):e52–e. PMCID: PMC5325924 [PMC free article] [PubMed] [Google Scholar]
  • 52.Enhancing the QUAlity and Transparency Of health Research. The EQUATOR Network. Centre for Statistics in Medicine (CSM), NDORMS, University of Oxford. [cited 2021 Apr 1]. Available from: https://www.equator-network.org/about-us/. [Google Scholar]
  • 53.Wang T, Benedict N, Olsen KM, Luan R, Zhu X, Zhou N, et al. Effect of critical care pharmacist’s intervention on medication errors: A systematic review and meta-analysis of observational studies. J Crit Care. 2015;30(5):1101–6. doi: 10.1016/j.jcrc.2015.06.018 [DOI] [PubMed] [Google Scholar]
  • 54.Cohen V, Jellinek SP, Hatch A, Motov S. Effect of clinical pharmacists on care in the emergency department: a systematic review. Am J Health Syst Pharm. 2009;66(15):1353–61. doi: 10.2146/ajhp080304 [DOI] [PubMed] [Google Scholar]
  • 55.Maidment ID, Lelliott P, Paton C. Medication errors in mental healthcare: a systematic review. Qual Saf Health Care. 2006;15(6):409–13. doi: 10.1136/qshc.2006.018267 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Noormandi A, Karimzadeh I, Mirjalili M, Khalili H. Clinical and economic impacts of clinical pharmacists’ interventions in Iran: a systematic review. Daru. 2019;27(1):361–78. doi: 10.1007/s40199-019-00245-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Keers RN, Williams SD, Cooke J, Walsh T, Ashcroft DM. Impact of interventions designed to reduce medication administration errors in hospitals: a systematic review. Drug Saf. 2014;37(5):317–32. doi: 10.1007/s40264-014-0152-0 [DOI] [PubMed] [Google Scholar]
  • 58.Manias E, Kusljic S, Wu A. Interventions to reduce medication errors in adult medical and surgical settings: a systematic review. Therapeutic advances in drug safety. 2020;11. doi: 10.1177/2042098620968309 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Boyko EJ. Observational research—opportunities and limitations. J Diabetes Complications. 2013;27(6):642–8. doi: 10.1016/j.jdiacomp.2013.07.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Institute of Medicine (US) Committee on Quality of Health Care in America. To Err is Human: Building a Safer Health System. Washington (DC): National Academies Press (US), 2000. doi: 10.17226/9728 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Mojtaba Vaismoradi

27 Apr 2021

PONE-D-21-05743

Pharmacist-led educational interventions provided to healthcare providers to reduce medication errors: A systematic review and meta-analysis

PLOS ONE

Dear Dr. Jaam,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jun 11 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Prof, Mojtaba Vaismoradi, PhD, MScN, BScN

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

3. Please note that in order to use the direct billing option the corresponding author must be affiliated with the chosen institute. Please either amend your manuscript to change the affiliation or corresponding author, or email us at plosone@plos.org with a request to remove this option.

4. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ

5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer #1: REVIEWER’S COMMENTS

Pharmacist-led educational interventions provided to healthcare providers to reduce medication errors: A systematic review and meta-analysis

PONE-D-21-05743

GENERAL COMMENTS

The topic is highly relevant. To a large extent, the report followed the Preferred Reporting Items for Systematic revies and Meta-Analyses (PRISMA) Checklist. However, the manuscript needs significant editing for language and writing quality, to eliminate ambiguities. This would improve the fluidity and readability of the text. The authors should provide more explanations to make the Discussion section clearer. Readers might appreciate this section better, if comparisons/contrasts are made between their findings and those from similar studies while bringing to the fore the relevance in pharmacy practice. The manuscript could be accepted for publication if the necessary corrections are made in the revised submission.

ABSTRACT

1. Line 53: Write the full meaning of PROSPERO with the abbreviation in bracket. End the sentence with a full stop.

2. Line 54: … twelve (12) studies … (It is usually better not to start a sentence with figures)

3. Line 65: Preferably, arrange the keywords in alphabetical order separated by semi-colons.

4. General: Abstract is clear and gives a good description of the study.

INTRODUCTION

1. Line 70: Medication errors are defined …

2.Line 81: “safety” was mentioned twice

3. Lines 85 & 95: You can rephrase the statements without including the authors’ names.

4. Line 90: … have been reported to increase …

5 Line 91: … at the same time, reducing the …

6. Line 98: … aimed to …

MATERIALS AND METHODS

1. Line 103: The authors need to write the full meaning of PRISMA with the abbreviation in brackets. The authors should cite one of the original publications of the PRISMA Statement or PRISMA Explanation and Elaboration.

2. Line 104: Write the full meaning of PROSPERO with the abbreviation in brackets (In addition, correct the spelling of your abbreviation). The authors need to provide citation or where the review protocol can be accessed.

3. Line 112: … two researchers, independently, to ensure …

4. Line 114: … two authors, independently OR two independent authors.

5. Line 115: Category C – Did the authors mean to write “Reduce*”?

6. Lines 118 & 119: For clarity of the inclusion criteria, it needs to be rephrased. The authors can opt for the use of lower-case Roman numerals.

7. Line 120: It is unnecessary to include “regardless of study design” as this creates ambiguity.

8. Lines 121 – 124: For clarity of the exclusion criteria, the authors can use lower-case Roman numerals for the listing.

9. Line 123: … led by students …

10 Line 131: … two independent researchers …

11. Line 133: Include citation for the Crowe Critical Appraisal Tool (CCAT)

12. Line 135: Each domain has a maximum score of five … (Write single digits as words)

13. Line 137: … two independent researchers …

14. Line 137/8: The CCAT was previously …

RESULTS

1. Line 149: … (n = 6857), the remaining articles …

2. Line 150: … two researchers. A total of 12 articles …

3. Line 166: Additionally, …

4. Line 167: Delete “or”

5. Table 2: The contents for the “medication error rate post-intervention” column is confusing. What do the figures after the duration in round brackets represent? Is this captured in the heading?

6. General: Be uniform in your report of the percentages and figures. Use either one decimal place or two decimal places.

Be consistent with how you write post or pre-intervention. Is it post-intervention or postintervention? Be consistent.

“et al.” should be italicized.

7. Line 176: CCAT appraised …

8. Line 183/4: … that varied in content …

9. Line 188: … two weeks …

10. Line 191: … six studies …

11. Line 204: … that summarized …

12. Line 214: The last statement needs to be rephrased. Starting a statement with “Nor” could confuse readers.

13. Line 218: Do you mean the ten studies presented that P-value of 0.0004? Was this stated in the studies or calculated by the authors? If any of the P-values were by the authors, then it should reflect in the Methods section (data analysis and synthesis). The level of significance should be included.

DISCUSSION

1. General: The Discussion section needs to be improved. The authors seemed to focus on making comparisons between the studies that were included in their study. This was similar to Results summary. A more robust Discussion should provide possible reasons for the findings; compare/contrast the findings with other studies; relate the findings to pharmacy practice.

2. Line 232 – 234: This should be in the Introduction section, as it is a justification for conducting the study. It should not appear in the Discussion section. The introductory paragraph of the Discussion should be a summary of the findings without repeating the results.

3. Line 237/8: Do not report figures in your Discussion section, as they should already be in the Results section.

4. Line 245: one month or 1-month

5. Line 267 – 269: Sentence should be rephrased.

6. Line 273 – 274: Sentence should be rephrased. It appears incomplete.

7. General: The use of different referencing styles should be corrected all through the manuscript.

8. Line 281 – 285: Sentence is complex and can be broken into simple sentences. For clarity, it is better to have two simple sentences than have one extremely long sentence with multiple punctuation marks and conjunctions.

9. Line 287: … In lieu, …

10. Line 289: … site-specific, based …

11. Line 291/2: The sentence should be rephrased.

12. Line 294: delete “All in all”.

13. Line 294: … the included studies …

14. Line 295: … CCAT …

15. Line 301: Write the full meaning of EQUATOR with the abbreviation in bracket.

16. Line 309: … was reported. (Delete “and was expected”)

17: General: The limitations were well described.

18. Line 340: Do you mean “To err is human”?

CONCLUSION

1. Line 348/9: It is not necessary to include the overall odds ratio in the Conclusion.

2. Line 350: … that summarize …

CONTRIBUTIONS

Line 365 – 368: All authors should be mentioned. All authors should be represented by their full abbreviations.

REFERENCES

1. Please follow the authors’ guidelines. There should be uniformity in the References. For instance, some Journal titles are abbreviated while others are not e.g., Reference 4, 11, 42. Check all.

2. Reference 40, 46: Include date cited.

FIGURES

1. Figure 1: The descriptions on the far-left are upside down.

2. Figure 1: The calculation is confusing as (9346 + 8) – 6857 = 2497 (The authors’ flow diagram shows 2498). The first sentence in the Results section confirms that 9354 articles were identified from the different databases and reference screening. The correct values should be inputted in the flow diagram.

Reviewer #2: Dear authors

I have several suggestions for improving your manuscript.

Abstract

1.Please write the sampling method, study design, and study time.

Introduction

2. I think it is better to remove the following sentence and add it to the end of the introduction before stating the purpose.

" This study sought to implement a remote corporate-based pharmacist into a home-based primary care practice to facilitate comprehensive medication reviews."

3. Please provide the references in the following sentences.

Line:79, 97,

4. At the end of line 175, change "a American…" to " an American….".

Methods

5. Please write the sampling method, study design, and study time.

6. Please explain inclusion and exclusion criteria.

7. Please write ethical considerations.

Results

8. In Table 1, the total percentage in the payer's column is 99.9%, please correct.

9. In table 1, the term Std should be clarified.

10. Please use the full form of "VTE" first used in table 3.

Discussion

11. You can suggest conducting experimental studies such as Randomised Clinical Trial (RCT) for future studies.

Best regards

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Jun 23;16(6):e0253588. doi: 10.1371/journal.pone.0253588.r002

Author response to Decision Letter 0


2 May 2021

Dear Madam/Sir,

Revision of Manuscript PONE-D-21-05743: Pharmacist-led educational interventions provided to healthcare providers to reduce medication errors: A systematic review and meta-analysis

The authors of the above-named manuscript would like to thank you for your e-mail dated 27 April 2021, containing the constructive comments of the reviewer. The authors very much appreciate the comments and have revised the manuscript accordingly as attached. We are positive that the comments helped in enhancing the quality and scientific merit of the paper.

Within the submission system we uploaded a document "Response to reviewers" which includes our response in details.

All in all, the article was reviewed for language and writing with adjustments made throughout. Additionally, the discussion was adjusted to accommodate the reviewer’s comment which we believe adds value to the manuscript.

We also wish to clarify in response to this comment: 5. Line 115: Category C – Did the authors mean to write “Reduce*”?

The authors used * to capture the following: Reduction, Reducing, Reduce. This was not a typo.

Everything else was fully addressed including comments received from Reviewer #2.

Thank you to the editor and the reviewer for the time spent on this manuscript. We look forward to receiving your kind response.

Sincerely yours,

The Corresponding Author

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Mojtaba Vaismoradi

26 May 2021

PONE-D-21-05743R1

Pharmacist-led educational interventions provided to healthcare providers to reduce medication errors: A systematic review and meta-analysis

PLOS ONE

Dear Dr. Jaam,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jul 10 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Prof Mojtaba Vaismoradi, PhD, MScN, BScN

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer #1: Review Comments to the Author

Pharmacist-led educational interventions provided to healthcare providers to reduce medication errors: A systematic review and meta-analysis

PONE-D-21-05743R1

GENERAL COMMENTS

The revised manuscript addressed the concerns in the first revision. The manuscript should be accepted for publication after the few corrections, stated below, are effected.

MATERIALS AND METHODS

Lines 103: meta-analyses (more appropriate in its plural form)

DISCUSSION

1. Line 228: et al.,

2. Line 303: Why is this line empty?

CONTRIBUTIONS

Line 346: Contributions

REFERENCES

Include date cited for accessed websites in References 40 & 46.

Reviewer #2: Dear authors

Thank you for your high-quality work. I have some minor comments for improving your manuscript.

1. In line 60 you stated " Studies reporting...." and mentioned only one reference, I checked the reference. Considering that the article is a systematic review study, it is better instead of " Studies reporting... " write" the results of a systematic review .... ". Because we are expected to refer to a number of articles when we mention the word "studies".

2.The introduction is well organized and follows a logical course. However, I suggest that it is better to mention the statistics of medication errors in the introduction section (about two or three sentences).

3.Please check the numbers in Table 3 again. The Overall Out of 40 of Fawaz et al study [21] is 23.5%, which is calculated in the table 25.5%.

4.Please correct the following:

Line 22: "increased" to " an increased or the increased " be corrected.

In line 143, the means of term "hospital" in the sentence "three covered emergency/acute care hospital" Is it hospital wards or hospitals?

Best regards

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Jun 23;16(6):e0253588. doi: 10.1371/journal.pone.0253588.r004

Author response to Decision Letter 1


30 May 2021

Response to reviewer 1: The authors thank the reviewer for their comments. The authors addressed all comments mentioned.

Response to reviewer 2: The authors appreciate the comments provided. All comments were addressed in the revised manuscript. More statistics relevant to the topic were added in the introduction. All numbers were reviewed within table 3 to ensure accuracy. Modification was made to correct the error. All other comments were fully addressed.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 2

Mojtaba Vaismoradi

9 Jun 2021

Pharmacist-led educational interventions provided to healthcare providers to reduce medication errors: A systematic review and meta-analysis

PONE-D-21-05743R2

Dear Dr. Jaam,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Prof, Mojtaba Vaismoradi, PhD, MScN, BScN

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Mojtaba Vaismoradi

15 Jun 2021

PONE-D-21-05743R2

Pharmacist-led educational interventions provided to healthcare providers to reduce medication errors: A systematic review and meta-analysis

Dear Dr. Jaam:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Professor Mojtaba Vaismoradi

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Checklist. PRISMA checklist.

    (DOC)

    S1 File. Search strategy.

    (DOCX)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES